COVID-19 Vaccine Task Force and Conflicts of Interest
- PMID: 35319440
- PMCID: PMC8935919
- DOI: 10.12927/hcpol.2022.26732
COVID-19 Vaccine Task Force and Conflicts of Interest
Abstract
Early in the COVID-19 pandemic, the federal government established a COVID-19 Vaccine Task Force to provide it with recommendations on a wide variety of issues related to vaccines. This article explores how the conflicts of interest of the Task Force members are declared and managed and what the implications are for the advice that they offer to the government. The Canadian government needs to go beyond just managing conflicts and work toward eliminating them on the Task Force.
Au début de la pandémie de la COVID-19, le gouvernement fédéral a créé le groupe de travail sur les vaccins contre la COVID-19, qui avait comme tâche de formuler des recommandations sur une grande variété de questions liées aux vaccins. L'article explore comment les conflits d'intérêts des membres du groupe de travail sont déclarés et gérés et quelles en sont les répercussions sur les conseils qu'ils donnent au gouvernement. Le gouvernement du Canada doit aller au-delà de la simple gestion des conflits et s'efforcer de les éliminer au sein du groupe de travail.
Copyright © 2022 Longwoods Publishing.
Comment in
-
Commentary - From Transparency to Accountability: Finding Ways to Make Expert Advice Trustworthy.Healthc Policy. 2022 Feb;17(3):28-33. doi: 10.12927/hcpol.2022.26731. Healthc Policy. 2022. PMID: 35319441 Free PMC article.
Similar articles
-
Commentary - From Transparency to Accountability: Finding Ways to Make Expert Advice Trustworthy.Healthc Policy. 2022 Feb;17(3):28-33. doi: 10.12927/hcpol.2022.26731. Healthc Policy. 2022. PMID: 35319441 Free PMC article.
-
Canada is no global health leader on COVID-19 vaccine equity.Lancet. 2021 May 15;397(10287):1803. doi: 10.1016/S0140-6736(21)00888-6. Lancet. 2021. PMID: 33992135 No abstract available.
-
An equitable vaccine delivery system: Lessons from the COVID-19 vaccine rollout in Canada.PLoS One. 2022 Dec 30;17(12):e0279929. doi: 10.1371/journal.pone.0279929. eCollection 2022. PLoS One. 2022. PMID: 36584230 Free PMC article.
-
A review of approved COVID-19 vaccines.Rocz Panstw Zakl Hig. 2021;72(3):245-252. doi: 10.32394/rpzh.2021.0177. Rocz Panstw Zakl Hig. 2021. PMID: 34553878 Review.
-
International COVID-19 vaccine inequality amid the pandemic: Perpetuating a global crisis?J Glob Health. 2021 Jul 3;11:03086. doi: 10.7189/jogh.11.03086. J Glob Health. 2021. PMID: 34221356 Free PMC article. Review. No abstract available.
Cited by
-
Canada and the pharmaceutical industry in the time of COVID-19.Int J Soc Determinants Health Health Serv. 2023 Oct;53(4):508-517. doi: 10.1177/27551938231195434. Epub 2023 Aug 13. Int J Soc Determinants Health Health Serv. 2023. PMID: 37574784 Free PMC article.
-
Biopharmaceutical Financialization and Public Funding of Medical Countermeasures (MCMs) in Canada During the COVID-19 Pandemic.Int J Health Policy Manag. 2023;12:6936. doi: 10.34172/ijhpm.2023.6936. Epub 2023 May 27. Int J Health Policy Manag. 2023. PMID: 37579382 Free PMC article.
-
Mobilization of science advice by the Canadian federal government to support the COVID-19 pandemic response.Humanit Soc Sci Commun. 2023;10(1):19. doi: 10.1057/s41599-023-01501-8. Epub 2023 Jan 17. Humanit Soc Sci Commun. 2023. PMID: 36687774 Free PMC article.
-
Addressing conflicts of interest regarding the vaccine in infectious disease outbreaks based on good governance for health approach: a policy brief.BMC Health Serv Res. 2023 Sep 25;23(1):1028. doi: 10.1186/s12913-023-10020-w. BMC Health Serv Res. 2023. PMID: 37749540 Free PMC article. Review.
-
Health Services and Policy Research in Canada: An Editor's Reflections.Healthc Policy. 2022 Feb;17(3):6-14. doi: 10.12927/hcpol.2022.26735. Healthc Policy. 2022. PMID: 35319437 Free PMC article.
References
-
- Ballingall A. 2021, May 18. Ottawa Is Putting up Almost $200 Million to Help a Mississauga Company Mass Produce Vaccines. Toronto Star. Retrieved May 30, 2021. <https://www.thestar.com/politics/federal/2021/05/18/ottawa-is-putting-up...>.
-
- Cain D.M., Loewenstein G., Moore D.A.. 2005. The Dirt on Coming Clean: Perverse Effects of Disclosing Conflicts of Interest. The Journal of Legal Studies 34(1): 1–25. doi:10.1086/426699.
-
- Canadian Agency for Drugs and Technology in Health (CADTH). n.d. Conflict of Interest Guidelines for CADTH Expert Committee and Panel Members. Retrieved January 15, 2021. <https://www.cadth.ca/media/corporate/corp_committees/cadth_coi_guideline...>.
-
- Centers for Medicare & Medicaid Services. 2013, February 8. Medicare, Medicaid, Children's Health Insurance Programs; Transparency Reports and Reporting of Physician Ownership or Investment Interests; Final Rule. Federal Register Vol. 78, No. 27. Retrieved January 21, 2022. <https://www.cms.gov/OpenPayments/Downloads/Affordable-Care-Act-Section-6...>. - PubMed
-
- Dougherty K. 2020, September 21. Leading Vaccine Developer Walks Out on Federal Vaccine Task Force. iPolitics. Retrieved May 30, 2021. <https://ipolitics.ca/2020/09/21/leading-vaccine-developer-walks-out-on-f...>.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical